Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Incyclinide is a non-antimicrobial chemically modified tetracycline (CMT) and an inhibitor of matrix metalloproteinase-13 (MMP-13), MMP-1, and MMP-8 (IC50s = 0.3, 34, and 48 µg/ml, respectively).1 It inhibits chick osteoclast digestion of isolated bovine bone when used at a concentration of 5 µg/ml and inhibits IL-1-induced glycosaminoglycan release from porcine articular cartilage explants at 10 µg/ml. Incyclinide (10 µM) also induces cytotoxicity of HeLa and SiHa human cervical cancer cells, as well as induces apoptosis in HeLa cells and cell cycle arrest at the G0/G1 phase in SiHa cells.2
WARNING This product is not for human or veterinary use.
1. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship to bone and cartilage degradation. Bone 22(1), 33-38 (1998).
2. Inhibitory impacts of chemically modified tetracycline-